Synapse

← Gordon B. Mills

Papers by Gordon B. Mills

Page 10 · newest first

  1. Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancerOncotarget · 2014
  2. A curated census of autophagy-modulating proteins and small moleculesAutophagy · 2014
  3. Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop ReportMolecular & Cellular Proteomics · 2014
  4. Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearanceJournal of Clinical Investigation · 2014
  5. Genetic and Pharmacological Strategies to Refunctionalize the von Hippel Lindau R167Q Mutant ProteinCancer Research · 2014
  6. Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein LevelsMolecular & Cellular Proteomics · 2014
  7. YB-1 Transforms Human Mammary Epithelial Cells Through Chromatin Remodeling Leading to the Development of Basal-Like Breast CancerStem Cells · 2014
  8. Concordance of Genomic Alterations between Primary and Recurrent Breast CancerMolecular Cancer Therapeutics · 2014
  9. Reverse-Phase Protein Array Profiling of Oropharyngeal Cancer and Significance of PIK3CA Mutations in HPV-Associated Head and Neck CancerClinical Cancer Research · 2014
  10. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylationBMC Cancer · 2014
  11. Comprehensive molecular characterization of urothelial bladder carcinomaNature · 2014
  12. Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancerProceedings of the National Academy of Sciences · 2014
  13. Bias from removing read duplication in ultra-deep sequencing experimentsBioinformatics · 2014
  14. OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasetsMolecular Cancer · 2014
  15. A Comprehensive Comparison of Normalization Methods for Loading Control and Variance Stabilization of Reverse-Phase Protein Array DataCancer Informatics · 2014
  16. cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast CancerJournal of Cancer · 2014
  17. Perturbation Biology: Inferring Signaling Networks in Cellular SystemsPLoS Computational Biology · 2013
  18. A Genetic Mouse Model of Invasive Endometrial Cancer Driven by Concurrent Loss of Pten and Lkb1 Is Highly Responsive to mTOR InhibitionCancer Research · 2013
  19. Differences in Gene and Protein Expression and the Effects of Race/Ethnicity on Breast Cancer SubtypesCancer Epidemiology Biomarkers & Prevention · 2013
  20. An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulationOncogene · 2013
  21. Proteomic Characterization of Breast Cancer Xenografts Identifies Early and Late Bevacizumab-Induced Responses and Predicts Effective Drug CombinationsClinical Cancer Research · 2013
  22. Modeling precision treatment of breast cancerGenome biology · 2013
  23. CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized FeaturesPLoS ONE · 2013
  24. Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications · 2013
  25. Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung CancerClinical Cancer Research · 2013
  26. The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics · 2013
  27. TCPA: a resource for cancer functional proteomics dataNature Methods · 2013
  28. Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cellsCancer & Metabolism · 2013
  29. Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived XenograftsCell Reports · 2013
  30. Predicting time to ovarian carcinoma recurrence using protein markersJournal of Clinical Investigation · 2013
  31. LKB1 is a central regulator of tumor initiation and pro-growth metabolism in ErbB2-mediated breast cancerCancer & Metabolism · 2013
  32. Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaPLoS ONE · 2013
  33. A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft ModelsCancer Research · 2013
  34. Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast CancerClinical Cancer Research · 2013
  35. AMPK: A Contextual Oncogene or Tumor Suppressor?Cancer Research · 2013
  36. Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8Cancer Research · 2013
  37. Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive BiomarkersCancer Discovery · 2013
  38. Building a Personalized Medicine Infrastructure at a Major Cancer CenterJournal of Clinical Oncology · 2013
  39. Systematic Identification of Combinatorial Drivers and Targets in Cancer Cell LinesPLoS ONE · 2013
  40. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteinsMolecular Oncology · 2013
  41. Network inference using steady-state data and Goldbeter–Koshland kineticsBioinformatics · 2013
  42. EVI1 splice variants modulate functional responses in ovarian cancer cellsMolecular Oncology · 2013
  43. Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520Hepatology · 2013
  44. BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutationMolecular Oncology · 2013
  45. BSTA Promotes mTORC2-Mediated Phosphorylation of Akt1 to Suppress Expression of FoxC2 and Stimulate Adipocyte DifferentiationScience Signaling · 2013
  46. Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating AgentsClinical Cancer Research · 2012
  47. Soft tissue sarcoma subtypes exhibit distinct patterns of acquired uniparental disomyBMC Medical Genomics · 2012
  48. Rab25 in cancer: a brief updateBiochemical Society Transactions · 2012
  49. Somatic Mutations of PIK3R1 Promote GliomagenesisSHILAP Revista de lepidopterología · 2012
  50. An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor ResistanceClinical Cancer Research · 2012